News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on LTR Pharma.
RELATED STOCKHEAD STORIES
Stockhead TV
Break it Down: LTR Pharma prescribes ED spray under TGA scheme
Health & Biotech
Patients uplifted by LTR Pharma’s ED treatment Spontan under TGA scheme
Health & Biotech
ASX Health Stocks: PYC’s visionary drug shows promise; Spontan ED spray available under TGA program
Health & Biotech
ScoPo’s Powerplays: ASX health stocks up in ‘fairly lacklustre week’
Health & Biotech
LTR Pharma raises $10.5m to advance erectile dysfunction treatment SPONTAN
Health & Biotech
The ASX biotechs with secured FDA clearances in 2024, and others looking likely
News
Closing Bell: Most ASX sectors flashing red today, as RAU makes solid market debut
News
ASX Small Caps Lunch Wrap: Has science unveiled Australia’s ultimate Murder Bird this week?
News
Rise and Shine: Everything you need to know before the ASX opens
News
Closing Bell: Joy as LTR Pharma stands proud and delight as ASX diggers inject miner surprise
News
ASX Small Caps Lunch Wrap: Whose wonderful waterfall is a big, fat phony this week?
Stockhead TV
Break it Down: LTR Pharma flexes SPONTAN spray success
News
Closing Bell: Aussie shares slip on commodities dip; but Goldies soar on rates hopes
Health & Biotech
ASX Health Winners in May: LTR Pharma leads, and why hopes are high for biotech stocks this year
Health & Biotech
Check Up: Alzheimer’s is ‘preventable’, so here’s what you must do; and recent ASX biotech winners
News
Closing Bell: Webjet to split, BHP’s deadline dilemma, and Charger Metals up 70pc on lithium find
Health & Biotech
